Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1700 of 2873 entries
View as:

Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005991 Org: User:
Start: 08/25/97 End: 02/14/03 Due: 02/14/04

Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets

Phase: N/A Priority: Normal
NCT ID: NCT00074763 Org: User:
Start: 07/31/03 End: 01/31/06 Due: 01/31/07

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)

Phase: N/A Priority: Normal
NCT ID: NCT01927718 Org: User:
Start: 01/31/14 End: 11/30/16 Due: 11/30/17

Automated Pain Intervention for Underserved Minority Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00881010 Org: User:
Start: 02/28/09 End: 02/12/19 Due: 02/12/20

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT05804227 Org: User:
Start: 04/20/23 End: 09/22/27 Due: 09/22/28

Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00307710 Org: User:
Start: 08/31/04 End: 02/28/07 Due: 02/28/08

A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care

Phase: N/A Priority: Normal
NCT ID: NCT05488444 Org: User:
Start: 08/25/22 End: 10/17/23 Due: 10/17/24

A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06297629 Org: User:
Start: 07/01/24 End: 07/11/24 Due: 07/11/25

Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00824174 Org: User:
Start: 12/31/08 End: - Due: -

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01471067 Org: User:
Start: 07/13/12 End: 04/25/17 Due: 04/25/18

Lenalidomide and Obinutuzumab in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02225275 Org: User:
Start: 03/31/16 End: 05/19/21 Due: 05/19/22

Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00963859 Org: User:
Start: 10/31/07 End: 06/30/11 Due: 06/30/12

Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases

Phase: N/A Priority: Normal
NCT ID: NCT02387905 Org: User:
Start: 03/09/15 End: 12/31/26 Due: 12/31/27

Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00354978 Org: User:
Start: 01/31/05 End: 03/31/11 Due: 03/31/12

Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05058339 Org: User:
Start: 04/27/21 End: 09/06/24 Due: 09/06/25

Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00112996 Org: User:
Start: 01/31/07 End: 04/30/14 Due: 04/30/15

Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00267059 Org: User:
Start: 12/31/05 End: 08/31/09 Due: 08/31/10

A Study for Leukemia Patients With Life-Threatening Infections

Phase: N/A Priority: Normal
NCT ID: NCT00968838 Org: User:
Start: 04/30/09 End: 08/31/11 Due: 08/31/12

Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02392637 Org: User:
Start: 04/02/15 End: 08/13/20 Due: 08/13/21

Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02530515 Org: User:
Start: 12/18/15 End: 04/30/18 Due: 04/30/19

A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use

Phase: N/A Priority: Normal
NCT ID: NCT05589857 Org: User:
Start: 10/25/22 End: 05/09/24 Due: 05/09/25

Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG

Phase: N/A Priority: Normal
NCT ID: NCT01815346 Org: User:
Start: 07/06/14 End: 05/10/16 Due: 05/10/17

Olanzapine in Patients With Advanced Cancer and Weight Loss

Phase: N/A Priority: Normal
NCT ID: NCT00489593 Org: User:
Start: 10/31/06 End: 12/31/13 Due: 12/31/14

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Phase: N/A Priority: Normal
NCT ID: NCT01010217 Org: User:
Start: 11/05/09 End: 10/05/17 Due: 10/05/18

A Pilot Study Assessing the Effectiveness of Use of Guided Imagery for Treatment of Pain and Symptom Management in Women With Post-mastectomy Pain Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05408741 Org: User:
Start: 06/06/22 End: 05/10/24 Due: 05/10/25